Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Ponzoni, M."" wg kryterium: Autor

  Lista filtrów
Wyrównaj
    Wyświetlanie 1-19 z 19
    Tytuł:
    Rescue of Hippo coactivator YAP1 triggers DNA damage-induced apoptosis in hematological cancers.
    Autorzy:
    Cottini F; 1] Department of Medical Oncology, Jerome Lipper Multiple Myeloma Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA. [2] Functional Genomics of Cancer Unit, Division of Molecular Oncology, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) San Raffaele Scientific Institute, Milan, Italy.
    Hideshima T; Department of Medical Oncology, Jerome Lipper Multiple Myeloma Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA.
    Xu C; 1] Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA. [2] Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA. [3] Ludwig Center at Dana-Farber/Harvard Cancer Center, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
    Sattler M; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA.
    Dori M; Functional Genomics of Cancer Unit, Division of Molecular Oncology, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) San Raffaele Scientific Institute, Milan, Italy.
    Agnelli L; Hematology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
    ten Hacken E; Laboratory of Lymphoid Malignancies, Division of Molecular Oncology, IRCCS San Raffaele Scientific Institute, Milan, Italy.
    Bertilaccio MT; Laboratory of Lymphoid Malignancies, Division of Molecular Oncology, IRCCS San Raffaele Scientific Institute, Milan, Italy.
    Antonini E; Functional Genomics of Cancer Unit, Division of Molecular Oncology, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) San Raffaele Scientific Institute, Milan, Italy.
    Neri A; Hematology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
    Ponzoni M; Pathology Unit, Myeloma Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy.
    Marcatti M; Department of Hematology-Oncology, Hematology and Bone Marrow Transplantation Unit, Myeloma Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy.
    Richardson PG; Department of Medical Oncology, Jerome Lipper Multiple Myeloma Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA.
    Carrasco R; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA.
    Kimmelman AC; Department of Radiation Oncology, Division of Genomic Stability and DNA Repair, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA.
    Wong KK; 1] Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA. [2] Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA. [3] Ludwig Center at Dana-Farber/Harvard Cancer Center, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
    Caligaris-Cappio F; 1] Laboratory of Lymphoid Malignancies, Division of Molecular Oncology, IRCCS San Raffaele Scientific Institute, Milan, Italy. [2] Università Vita-Salute San Raffaele, Milan, Italy. [3] MAGIC (Microenvironment and Genes in Cancers of the blood) Interdivisional Research Program, IRCCS San Raffaele Scientific Institute, Milan, Italy.
    Blandino G; Translational Oncogenomic Unit, Italian National Cancer Institute 'Regina Elena', Rome, Italy.
    Kuehl WM; Genetics Branch, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, USA.
    Anderson KC; 1] Department of Medical Oncology, Jerome Lipper Multiple Myeloma Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA. [2].
    Tonon G; 1] Functional Genomics of Cancer Unit, Division of Molecular Oncology, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) San Raffaele Scientific Institute, Milan, Italy. [2] Università Vita-Salute San Raffaele, Milan, Italy. [3] MAGIC (Microenvironment and Genes in Cancers of the blood) Interdivisional Research Program, IRCCS San Raffaele Scientific Institute, Milan, Italy. [4].
    Pokaż więcej
    Źródło:
    Nature medicine [Nat Med] 2014 Jun; Vol. 20 (6), pp. 599-606. Date of Electronic Publication: 2014 May 11.
    Typ publikacji:
    Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
    MeSH Terms:
    Adaptor Proteins, Signal Transducing/*genetics
    Apoptosis/*genetics
    DNA Damage/*genetics
    Genomic Instability/*genetics
    Hematologic Neoplasms/*genetics
    Phosphoproteins/*genetics
    Protein Serine-Threonine Kinases/*genetics
    Active Transport, Cell Nucleus/physiology ; Adaptor Proteins, Signal Transducing/metabolism ; Analysis of Variance ; Blotting, Western ; Boronic Acids ; Bortezomib ; DNA Primers/genetics ; Doxorubicin ; Fluorescent Antibody Technique ; Genetic Vectors/genetics ; Humans ; Immunohistochemistry ; Immunoprecipitation ; Intracellular Signaling Peptides and Proteins ; Phosphoproteins/metabolism ; Proto-Oncogene Proteins c-abl/metabolism ; Pyrazines ; Real-Time Polymerase Chain Reaction ; Transcription Factors ; YAP-Signaling Proteins
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
    Tytuł:
    Expression of DeltaNp73 is a molecular marker for adverse outcome in neuroblastoma patients.
    Autorzy:
    Casciano I; Laboratory of Population Genetics, Istituto Nazionale per la Ricerca sul Cancro (IST), Largo Rosanna Benzi 10, 16132 Genova, Italy.
    Mazzocco K
    Boni L
    Pagnan G
    Banelli B
    Allemanni G
    Ponzoni M
    Tonini GP
    Romani M
    Pokaż więcej
    Źródło:
    Cell death and differentiation [Cell Death Differ] 2002 Mar; Vol. 9 (3), pp. 246-51.
    Typ publikacji:
    Journal Article; Research Support, Non-U.S. Gov't
    MeSH Terms:
    Apoptosis/*physiology
    Neuroblastoma/*diagnosis
    Child ; Child, Preschool ; DNA-Binding Proteins/biosynthesis ; DNA-Binding Proteins/genetics ; Genes, Tumor Suppressor ; Humans ; Infant ; Infant, Newborn ; Neuroblastoma/mortality ; Nuclear Proteins/biosynthesis ; Nuclear Proteins/genetics ; Prognosis ; Protein Isoforms/biosynthesis ; Protein Isoforms/genetics ; Survival Rate ; Tumor Protein p73 ; Tumor Suppressor Proteins
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
    Tytuł:
    Different p73 splicing variants are expressed in distinct tumour areas of a multifocal neuroblastoma.
    Autorzy:
    Casciano I
    Ponzoni M
    Lo Cunsolo C
    Tonini GP
    Romani M
    Pokaż więcej
    Źródło:
    Cell death and differentiation [Cell Death Differ] 1999 May; Vol. 6 (5), pp. 391-3.
    Typ publikacji:
    Letter; Research Support, Non-U.S. Gov't
    MeSH Terms:
    Alternative Splicing*
    Apoptosis*
    Genes, Tumor Suppressor*
    Genetic Variation*
    DNA-Binding Proteins/*genetics
    Neuroblastoma/*genetics
    Nuclear Proteins/*genetics
    Humans ; Neuroblastoma/pathology ; Tumor Protein p73 ; Tumor Suppressor Proteins
    Raport
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
      Wyświetlanie 1-19 z 19

      Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies